Recent Finacing
Recent Raise
Grit Biotechnology is a Shanghai cell‑therapy company developing tumor‑infiltrating lymphocyte (TIL) therapies—GT101 advancing to Phase II, gene‑edited TILs, and four platforms including ImmuT Finder CRISPR screening.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at GRIT Biotechnology.
